Anti-angiogenesis by lentivirus-mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma

Technology in Cancer Research and Treatment

Volumn 10, Issue 4, 2011, Pages 361-369

  Zhou, J ^a   Zhang, Z X ^a   Zhao, H ^a   Zhu, D M ^a   Zhang, Y ^a   Li, D C ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Angiogenesis; Angiopoietin 2; Gene therapy; Pancreatic carcinoma; RNA interference

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANGIOPOIETIN 2; BETA ACTIN; CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; SMALL INTERFERING RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL VIABILITY; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WESTERN BLOTTING;

EID: 80053230783     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500213     Document Type: Article

References (30)

1. Hidalgo, M. Pancreatic cancer. N Engl J Med 362, 1605-1617 (2010).
2. Ghaneh, P., Costello, E., Neoptolemos, J. P. Biology and management of pancreatic cancer. Postgrad Med J 84, 478-497 (2008).
3. Pan, X., Sheng, W. H., Zhu, Q. Y., Xie, Y. F., Ye, Z. M., Xiang, J., Li, D. C., Yang, J. C. Inhibition of pancreatic carcinoma growth by adenovirus-mediated human interleukin-24 expression in animal model. Cancer Biother Radio 23, 425-434 (2008).
4. Folkman, J. Tumor angiogenesis: a possible control point in tumor growth. Ann Intern Med 82, 96-100 (1975).
5. Kerbel, R. S. Tumor angiogenesis. New Engl J Med 358, 2039-2049 (2008).
6. Dai, J., Rabie, A. B. M. VEGF: an essential mediator of both angio- genesis and endo- chondral ossification. J Dent Res 86, 937-950 (2007).
7. Midgley, R., Kerr, D. Bevacizumab-current status and future directions. Ann Oncol 16, 999-1004 (2005).
8. Girling, J. E., Rogers, P. A. W. Regulation of endometrial vascular remodelling: role of the vascular endothelial growth factor family and the angiopoietin-TIE signalling system. Reproduction 138, 883-893 (2009).
9. Lewis, C. E., De Palma, M., Naldini, L. Tie2-Expressing monocytes and tumor angio- genesis: regulation by hypoxia and angiopoietin-2. Cancer Res 67, 8429-8432 (2007).
10. Park, J. H., Park, K. J., Kim, Y. S., Sheen, S. S., Lee, K. S., Lee, H. N., Oh, Y. J., Hwang, S. C. Serum angiopoietin-2 as a clinical marker for lung cancer. Chest 132, 200-206 (2007).
11. Detjen, K. M., Rieke, S., Deters, A., Schulz, P., Rexin, A., Vollmer, S., Hauff, P., Wiedenmann, B., Pavel, M., Scholz, A. Angiopoietin-2 promotes disease progression of neuroendocrine tumors. Clin Cancer Res 16, 420-429 (2010).
12. Helfrich, I., Edler, L., Sucker, A., Thomas, M., Christian, S., Schadendorf, D., Augustin, H. G. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Clin Cancer Res 15, 1384-1392 (2009).
13. Guo, P., Imanishi, Y., Cackowski, F. C., Jarzynka, M. J., Tao, H. Q., Nishikawa, R., Hirose, T., Hu, B., Cheng, S. Y. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metal- loprotease, and laminin 5 correlates with the invasiveness of human glioma. Am J Pathol 166, 877-890 (2005).
14. Merritt, W. M., Bar-Eli, M., Sood, A. K. The dicey role of dicer: implications for RNAi therapy. Cancer Res 70, 2571-2574 (2010).
15. Agrawal, N., Dasaradhi, P. V. N., Mohmmed, A., Malhotra, P., Bhatnagar, R. K., Mukherjee, S. K. RNA interference: biology, mechanism, and applications. Microbiol Mol Biol R 67, 657-685 (2003).
16. Chen, C. G., Tang, P., Yue, J., Ren, P., Liu, X. M., Zhao, X. J., Yu, Z.T. Effect of siRNA targeting HIF-1 alpha combined L-ascorbate on biological behavior of hypoxic MiaPaCa2 Cells. Technol Cancer Res Treat 8, 235-240 (2009).
17. Zhang, J., Zhang, Q. Y., Fu, Y. C., Wang, T., Zhang, J., Xu, P., Zhou, X., Pu, P. Y., Kang, C. S. Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo. Technol Cancer Res Treat 8, 467-478 (2009).
18. Buchschacher, G. L., Wong-Staal, F. Development of lentiviral vectors for gene therapy for human diseases. Blood 95, 2499-2504 (2000).
19. Naldini, L. A Comeback for Gene Therapy. Science 326, 805-806 (2009).
20. Brooks, P. C., Clark, R. A., Cheresh, D. A. Requirement of vascular integrin alpha v beta 3 for angiogenesis.Science 264, 569-571 (1994).
21. Takhar, A. S., Palaniappan, P., Dhingsa, R., Lobo, D. N. Recent developments in diagnosis of pancreatic cancer. Brit Med J 329, 668-673 (2004).
22. Jimeno, A., Hidalgo, M. Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther 5, 787-796 (2006).
23. Shapiro, R., Strydom, D. J., Olson, K. A., Vallee, B. L. Isolation of angiogenin from normal human plasma. Biochemistry 26, 5141-5146 (1987).
24. Yu, Q., Stamenkovic, I. Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am J Pathol 158, 563-570 (2001).
25. Durkin, A. J., Bloomston, M., Yeatman, T. J., Gilbert-Barness, E., Cojita, D., Rosemurgy, A. S., Zervos, E. E. Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors. J Am Coll Surgeons 199, 724-731 (2004).
26. Hanahan, D. Signaling vascular morphogenesis and maintenance. Science 277, 48 (1997).
27. Etoh, T., Inoue, H., Tanaka, S., Barnard, G. F., Kitano, S., Mori, M. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61, 2145-2153 (2001).
28. Zhang, L., Yang, N., Park, J. W., Katsaros, D., Fracchioli, S., Cao, G. Y., O'Brien-Jenkins, A., Randall, T. C., Rubin, S. C., Coukos, G. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 63, 34033412 (2003).
29. Krause, D. S., Fackler, M. J., Civin, C. I., May, W. S. CD34: structure, biology, and clinical utility. Blood 87, 1-13 (1996).
30. Nielsen, J. S., McNagny, K. M. Novel functions of the CD34 family. J Cell Sci 121, 3683-3692 (2008).